AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1510454
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg of rifampin twice daily on study days 6 and 7 (group A)
Trial: 1510454
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg of rifampin once daily on days 4, 5, 6, and 7 (group B)
Trial: 30554783
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg pegbelfermin once a day
Trial: 16816757
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous morphine
Trial: 11868800
Drug: roxithromycin 300
RxNorm normalized name: roxithromycin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: roxithromycin 300 mg daily for 5 days + 80 mg lovastatin
Trial: 11868800
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg lovastatin alone
Trial: 6093511
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of 0.5 g
Trial: 31184022
Drug: Docosahexaenoic acid
RxNorm normalized name: docosahexaenoic acid
DrugBank: Doconexent (DB03756)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docosahexaenoic acid (Brudi PLUS) 350 mg, 3 times a day for 90 days
Trial: 29475928
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (Thera tears, Wet therapy, Tears Naturale free)
Trial: 1563189
Drug: Antibiotic (14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic (14 days, n = 8)
Trial: 1563189
Drug: Bronchodilators and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bronchodilators and physiotherapy
Trial: 4082879
Drug: General anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anaesthesia (low‐dose fentanyl) and systemic morphine for postoperative pain
Trial: 25326007
Drug: Listening to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Listening to the radio daily
Trial: 22496085
Drug: Deferoxamine (DFO)
DrugBank: Deferoxamine (DB00746)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Deferoxamine (DFO) 500 mg intravenous bolus immediately before PPCI followed by a 12-hour infusion (50 mg/kg of body weight)
Trial: 12235692
Drug: Investigated group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Investigated group (carbohydrate metabolism disturbances)
Trial: 27591241
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (IvIg)
Trial: 28441896
Drug: Fluoxetine (⩽80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (⩽80 mg/day) for 12 weeks
Trial: 12921248
Drug: Cytotoxic therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytotoxic therapies (chlorambucil, cyclophosphamide)
Trial: 8739489
Drug: Continuous SCMC‐Lys
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous SCMC‐Lys 2.7 g once daily
Trial: 8739489
Drug: Intermittent SCMC‐Lys
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent SCMC‐Lys 2.7 g
Trial: 6797571
Drug: Tamoxifen 10
RxNorm normalized name: tamoxifen 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 10 mg by mouth twice daily
Trial: 25205644
Drug: Conventional medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional medical treatment
Trial: 3625582
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of positive and negative self-verbalizations (PSV + NSV)
Trial: 29478012
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group (IG): Medication adherence assessment.
Trial: 10834422
Drug: Placebo (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline injections)
Trial: 24567394
Drug: Repeated intergroup
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated intergroup contact with Spanish-speaking confederates inserted into daily routines for a period of days.
Trial: 15025402
Drug: Epinephrine (adrenaline)
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine (adrenaline) for out-of-hospital treatment of anaphylaxis; specific dosage not mentioned, but references to EpiPen Jr 0.15 mg and EpiPen 0.3 mg as available auto-injectors.
Trial: 15025402
Drug: Epinephrine administration
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine administration methods; subcutaneous injection or inhalation from a pressurized metered-dose inhaler instead of intramuscular injection.
Trial: 15025402
Drug: Fixed-dose formulations
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose formulations of epinephrine; specific formulations not mentioned.
Trial: 7959501
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg magnesium/day in the form of trimagnesium dieitrate
Trial: 3296735
Drug: Methylprednisolone (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (both doses)
Trial: 3296735
Drug: Methylprednisolone 375
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone 375 mg
Trial: 24487458
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension (BIS) 200 mcg 10 min prior to tracheal intubation and 6 and 24 h after extubation
Trial: 24487458
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension (BIS) 200 mcg 6 and 24 h after extubation
Trial: 23457130
Drug: 5 mg/Kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/Kg of tranexamic acid (TA)
Trial: 23457130
Drug: 15 mg/Kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/Kg of tranexamic acid (TA)
Trial: 15307697
Drug: Pulmicort inhalation
RxNorm normalized name: Pulmicort Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulmicort inhalation (WM)
Trial: 11606149
Drug: Study medications
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Study medications (Enalapril maleate, candesartan cilexetil, metoprolol succinate)
Trial: 21107951
Drug: Physiatric and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiatric and kinetic treatment (magnetotherapy)
Trial: 18272916
Drug: Chemotherapy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy followed by goserelin
Trial: 18272916
Drug: Chemotherapy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy followed by tamoxifen
Trial: 31157962
Drug: Endocrine therapy
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine therapy (tamoxifen alone)
Trial: 16940192
Drug: 5-methyltetrahydrofolate (5-MTHF)
RxNorm normalized name: 5-METHYLTETRAHYDROFOLIC ACID
DrugBank: 5-methyltetrahydrofolic acid (DB04789)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-methyltetrahydrofolate (5-MTHF) intravenous infusion
Trial: 12657408
Drug: ECT administered
RxNorm normalized name: ECT-001 expanded cord blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ECT administered soon (<210 sec) after anesthetic induction
Trial: 12657408
Drug: ECT administered
RxNorm normalized name: ECT-001 expanded cord blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ECT administered later (between 210 sec and 360 sec) after anesthetic induction
Trial: 10933121
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (d-amphetamine and Efamol)
Trial: 3924814
Drug: Augmentin (amoxycillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmentin (amoxycillin 3 g and potassium clavulanate 125 mg)
Trial: 3924814
Drug: Amoxycillin 3
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxycillin 3 g with probenecid 1 g by mouth
Trial: 21135532
Drug: Rowatinex® (special
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rowatinex® (special terpene combination; 3 × 2 capsules/day)
Trial: 17229225
Drug: Omeprazole magnesium
RxNorm normalized name: Omeprazole Magnesium
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole magnesium 20.6 mg o.m. (Ome-Mg 20)
Trial: 17229225
Drug: Famotidine 10
RxNorm normalized name: famotidine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine 10 mg b.d. (Fam 10)
Trial: 11677969
Drug: No injection
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No injection (control group) before polypectomy
Trial: 11677969
Drug: Submucosal epinephrine
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Submucosal epinephrine injection (1:10,000) before polypectomy
Trial: 9476184
Drug: Intravenous L-arginine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous L-arginine
Trial: 9476184
Drug: Chronic oral
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic oral intake of L-arginine
Trial: 2892807
Drug: Ro 16-8714
RxNorm normalized name: RO-5045337
DrugBank: RO-5045337 (DB14793)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ro 16-8714 (5 mg)
Trial: 2892807
Drug: Ro 16-8714
RxNorm normalized name: RO-5045337
DrugBank: RO-5045337 (DB14793)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ro 16-8714 (10 mg)
Trial: 2892807
Drug: Ro 16-8714
RxNorm normalized name: RO-5045337
DrugBank: RO-5045337 (DB14793)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ro 16-8714 (20 mg)
Trial: 23559149
Drug: FOLFOX4 plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOLFOX4 plus standard weekly cetuximab (arm 1)
Trial: 23559149
Drug: FOLFOX4 plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOLFOX4 plus cetuximab (500 mg/m(2)) every second week (arm 2)
Trial: 14675411
Drug: Aspirin (75-250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (75-250 mg/d)
Trial: 649865
Drug: No drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No drug with small monetary incentive
Trial: 30958544
Drug: Exenatide 5µg
RxNorm normalized name: Exenatide
DrugBank: Exenatide (DB01276)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exenatide 5µg twice daily for 2 weeks, then 10µg twice daily for 4 weeks
Trial: 28603135
Drug: Clopidogrel combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel combined with pantoprazole treatment
Trial: 28603135
Drug: Clopidogrel treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel treatment alone (Control)
Trial: 23095282
Drug: Anti-tumor necrosis
RxNorm normalized name: G 1 (anti-tumor agent)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-tumor necrosis factor-α therapy
Trial: 19631849
Drug: Coordinated treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coordinated treatment of periodontic and endodontic diseases
Trial: 15572280
Drug: Long-acting risperidone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting risperidone (active injections, dummy oral)
Trial: 15572280
Drug: Oral risperidone
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral risperidone (dummy injections, active oral)
Trial: 11988132
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg alendronate with 0.625 mg conjugated equine estrogens (CEE)
Trial: 11988132
Drug: Cyclic etidronate
RxNorm normalized name: etidronate
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cyclic etidronate with 0.625 mg CEE
Trial: 11988132
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg alendronate with 2 mg estradiol (E2)
Trial: 11988132
Drug: Combination regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination regimens (nandrolone decanoate plus calcitonin, calcitonin plus growth hormone (GH), pamidronate plus GH)
Trial: 20602694
Drug: Antiretroviral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral therapy adherence
Trial: 18436033
Drug: Pentazocine 50
RxNorm normalized name: pentazocine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentazocine 50 mg/0.5 mg naloxone (females)
Trial: 9014625
Drug: Thiopentone 4
RxNorm normalized name: Thiopentone
DrugBank: Thiopental (DB00599)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thiopentone 4 mg kg‐1 followed by a 15‐mg kg‐1 h‐1 continuous infusion
Trial: 1515878
Drug: Regimen A
RxNorm normalized name: CHLOROXYLENOL 5 g in 1000 mL TOPICAL SOAP [REGIMEN ANTIMICROBIAL]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen A (TBI dose 9 Gy)
Trial: 1515878
Drug: Regimen B
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen B (increased TBI dose rate and anthracyclines)
Trial: 6381185
Drug: Cimetidine 1.2
RxNorm normalized name: cimetidine 1.2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 1.2 g/day
Trial: 31407775
Drug: Vibration treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vibration treatment in addition to nasal cast with elastic bandage (group 3)
Trial: 23767097
Drug: Reamberin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reamberin (400 ml, two-week infusion)
Trial: 20352318
Drug: Diaphragm with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diaphragm with lubricant gel
Trial: 12514673
Drug: Isosorbide-5-mononitrate (IS-5-MN)
RxNorm normalized name: Isosorbide 5-mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide-5-mononitrate (IS-5-MN) 60 mg daily for 11 months
Trial: 2567114
Drug: Atenolol (50,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (50, 100 mg)
Trial: 9015908
Drug: Nisoldipine coat-core
RxNorm normalized name: Nisoldipine
DrugBank: Nisoldipine (DB00401)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nisoldipine coat-core (10, 20, 40 mg)
Trial: 8673754
Drug: Lacidipine 4
RxNorm normalized name: lacidipine 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacidipine 4 mg once daily
Trial: 1726000
Drug: Lacidipine 2
RxNorm normalized name: lacidipine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacidipine 2 mg once daily
Trial: 30545532
Drug: Platelet-rich plasma
RxNorm normalized name: PLATELET-RICH PLASMA, AUTOLOGOUS
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet-rich plasma (PRP) infusion (0.5-1 cc) in addition to HRT
Trial: 30545532
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement therapy (HRT) only
Trial: 27481035
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of inspiratory muscle training and functional electrical stimulation
Trial: 20526194
Drug: Casopitant 150
RxNorm normalized name: casopitant
DrugBank: Casopitant (DB06634)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casopitant 150 mg + Ondansetron 4 mg
Trial: 20526194
Drug: Ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 4 mg alone
Trial: 19055987
Drug: Clopidogrel 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 600 mg loading dose (LD) / 75 mg maintenance dose (MD) for 28 days
Trial: 19055987
Drug: Prasugrel 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 60 mg loading dose (LD) / 10 mg maintenance dose (MD) for 28 days
Trial: 15239618
Drug: Celsior (CEL)
RxNorm normalized name: Fraxinus excelsior leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celsior (CEL) solution
Trial: 3308980
Drug: Amikacin in
RxNorm normalized name: amikacin Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amikacin in combination with trimethoprim-sulfamethoxazole
Trial: 27328486
Drug: Desogestrel (DSG)
RxNorm normalized name: Desogestrel
DrugBank: Desogestrel (DB00304)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desogestrel (DSG) 150 mcg/ethinyl estradiol (EE) 20 mcg for 21 days followed by seven days of EE 10 mcg (21/7‐active)
Trial: 27328486
Drug: Desogestrel (DSG)
RxNorm normalized name: Desogestrel
DrugBank: Desogestrel (DB00304)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desogestrel (DSG) 150 mcg/ethinyl estradiol (EE) 20 mcg for 21 days followed by no treatment (DSG/EE+no Tx)
Trial: 22659624
Drug: bivalirudin 0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bivalirudin 0.75 mg/kg intravenous bolus followed by 1.75 mg/kg intravenous infusion per hour for 4 h
Trial: 20924150
Drug: Vinegar drink
RxNorm normalized name: Emergen-C Apple Cider Vinegar Drink Mix Powder for Solution (Apple)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vinegar drink (100 mL containing 750 mg acetic acid)
Trial: 20924150
Drug: Vinegar capsules
RxNorm normalized name: Sundance Apple Cider Vinegar Capsules
DrugBank: Acetic acid (DB03166)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vinegar capsules (9 capsules containing 750 mg acetic acid in total with 150 mL of water)
Trial: 20924150
Drug: Reference (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference (150 mL of water)
Trial: 20924150
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of AUC(capsule-ref) and AUC(drink-ref)
Trial: 8700339
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg piroxicam cinnamate
Trial: 1833543
Drug: 5 ml
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml isotonic saline (S)
Trial: 1833543
Drug: 5 ml
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml lignocaine, 0.5% (L)
Trial: 6227296
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and dipyridamole (ASA/DPM)
Trial: 30920059
Drug: Nd‐YAG 1064
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nd‐YAG 1064 nm laser treatment
Trial: 23132800
Drug: Group 1
RxNorm normalized name: Chlamydophila psittaci biogroup 1 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 1 (20 mg lutein and 2 mg zeaxanthin)
Trial: 20075646
Drug: Topiramate (25‐50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (25‐50 mg/d)
Trial: 18480522
Drug: IVPCA using
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVPCA using morphine
Trial: 12051399
Drug: Amtolmetin guacyl
RxNorm normalized name: Amtolmetin guacil
DrugBank: Amtolmetin guacil (DB16088)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amtolmetin guacyl (AMG) 1,200 mg over the first 3 days and 600 mg/day thereafter
Trial: 7733183
Drug: FOS-120 group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOS-120 group (120 mg/kg of body weight/day)
Trial: 7733183
Drug: FOS-90 group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOS-90 group (90 mg/kg of body weight/day)
Trial: 30024861
Drug: Adjuvanted varicella-zoster
RxNorm normalized name: varicella/zoster immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvanted varicella-zoster virus (VZV) glycoprotein E (gE) subunit herpes zoster vaccine (HZ/su)
Trial: 30247596
Drug: Live attenuated
RxNorm normalized name: mumps, live attenuated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live attenuated zoster vaccine (ZV)
Trial: 27836009
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol (200-1000 μg)
Trial: 15757769
Drug: Intravenous flucloxacillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous flucloxacillin on induction followed by an oral placebo (Group A)
Trial: 15757769
Drug: Intravenous flucloxacillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous flucloxacillin on induction followed by an oral flucloxacillin course (Group B)
Trial: 15757769
Drug: Oral placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral placebo (Group C)
Trial: 29191873
Drug: Endovascular therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular therapy (intervention group)
Trial: 27924798
Drug: Carbonated tap
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbonated tap water (placebo, 1 l/day for 6 weeks)
Trial: 21352112
Drug: OPUS treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OPUS treatment